Pharma companies worldwide are rapidly embracing breakthrough digital technologies with potential to transform the way they conduct their businesses. As the rate of digital innovation accelerates, spawning numerous new technologies, it is critical for companies to develop digital strategies to drive smart decision-making and help them achieve their business objectives.
Building on its more than $2 billion life sciences and medical technology investment portfolio, IFC has developed the DigiPharma advisory program for its clients. DigiPharma’s advisory package helps pharma companies plan, finance, and implement successful digital transformation strategies.
DECEMBER 2022
